As US billionaire Mark Cuban’s new generics venture takes off, the Mark Cuban Cost Plus Drug Company’s CEO, Alex Oshmyansky talks exclusively to Generics Bulletin about the motivation and purpose of the company.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?